Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 HIV POC
1.2.3 Clostridium Difficile POC
1.2.4 HBV POC
1.2.5 Respiratory Syncytial Virus POC
1.2.6 HPV POC
1.2.7 Influenza/Flu POC
1.2.8 HCV POC
1.2.9 MRSA POC
1.2.10 TB and Drug-Resistant TB POC
1.3 Market by Application
1.3.1 Global Point-of-care Infectious Disease Diagnostics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point-of-care Infectious Disease Diagnostics Market Perspective (2018-2033)
2.2 Point-of-care Infectious Disease Diagnostics Growth Trends by Region
2.2.1 Global Point-of-care Infectious Disease Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Point-of-care Infectious Disease Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 Point-of-care Infectious Disease Diagnostics Market Dynamics
2.3.1 Point-of-care Infectious Disease Diagnostics Industry Trends
2.3.2 Point-of-care Infectious Disease Diagnostics Market Drivers
2.3.3 Point-of-care Infectious Disease Diagnostics Market Challenges
2.3.4 Point-of-care Infectious Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue
3.1.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Point-of-care Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point-of-care Infectious Disease Diagnostics Revenue
3.4 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio
3.4.1 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Infectious Disease Diagnostics Revenue in 2022
3.5 Point-of-care Infectious Disease Diagnostics Key Players Head office and Area Served
3.6 Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Point-of-care Infectious Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-care Infectious Disease Diagnostics Breakdown Data by Type
4.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2024-2033)
5 Point-of-care Infectious Disease Diagnostics Breakdown Data by Application
5.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Point-of-care Infectious Disease Diagnostics Market Size (2018-2033)
6.2 North America Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2023)
6.4 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point-of-care Infectious Disease Diagnostics Market Size (2018-2033)
7.2 Europe Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2023)
7.4 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size (2018-2033)
8.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size (2018-2033)
9.2 Latin America Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size (2018-2033)
10.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Introduction
11.1.4 Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Point-of-care Infectious Disease Diagnostics Introduction
11.2.4 Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
11.2.5 Abbott Recent Development
11.3 Calypte Biomedical
11.3.1 Calypte Biomedical Company Detail
11.3.2 Calypte Biomedical Business Overview
11.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Introduction
11.3.4 Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
11.3.5 Calypte Biomedical Recent Development
11.4 Chembio Diagnostic Systems
11.4.1 Chembio Diagnostic Systems Company Detail
11.4.2 Chembio Diagnostic Systems Business Overview
11.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Introduction
11.4.4 Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
11.4.5 Chembio Diagnostic Systems Recent Development
11.5 Meridian Bioscience
11.5.1 Meridian Bioscience Company Detail
11.5.2 Meridian Bioscience Business Overview
11.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Introduction
11.5.4 Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
11.5.5 Meridian Bioscience Recent Development
11.6 MedMira
11.6.1 MedMira Company Detail
11.6.2 MedMira Business Overview
11.6.3 MedMira Point-of-care Infectious Disease Diagnostics Introduction
11.6.4 MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
11.6.5 MedMira Recent Development
11.7 Trinity Biotech
11.7.1 Trinity Biotech Company Detail
11.7.2 Trinity Biotech Business Overview
11.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Introduction
11.7.4 Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
11.7.5 Trinity Biotech Recent Development
11.8 Sekisui Diagnostics
11.8.1 Sekisui Diagnostics Company Detail
11.8.2 Sekisui Diagnostics Business Overview
11.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Introduction
11.8.4 Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
11.8.5 Sekisui Diagnostics Recent Development
11.9 OraSure Technologies
11.9.1 OraSure Technologies Company Detail
11.9.2 OraSure Technologies Business Overview
11.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Introduction
11.9.4 OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
11.9.5 OraSure Technologies Recent Development
11.10 Quidel
11.10.1 Quidel Company Detail
11.10.2 Quidel Business Overview
11.10.3 Quidel Point-of-care Infectious Disease Diagnostics Introduction
11.10.4 Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
11.10.5 Quidel Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of HIV POC
Table 3. Key Players of Clostridium Difficile POC
Table 4. Key Players of HBV POC
Table 5. Key Players of Respiratory Syncytial Virus POC
Table 6. Key Players of HPV POC
Table 7. Key Players of Influenza/Flu POC
Table 8. Key Players of HCV POC
Table 9. Key Players of MRSA POC
Table 10. Key Players of TB and Drug-Resistant TB POC
Table 11. Global Point-of-care Infectious Disease Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 12. Global Point-of-care Infectious Disease Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 13. Global Point-of-care Infectious Disease Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 14. Global Point-of-care Infectious Disease Diagnostics Market Share by Region (2018-2023)
Table 15. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 16. Global Point-of-care Infectious Disease Diagnostics Market Share by Region (2024-2033)
Table 17. Point-of-care Infectious Disease Diagnostics Market Trends
Table 18. Point-of-care Infectious Disease Diagnostics Market Drivers
Table 19. Point-of-care Infectious Disease Diagnostics Market Challenges
Table 20. Point-of-care Infectious Disease Diagnostics Market Restraints
Table 21. Global Point-of-care Infectious Disease Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 22. Global Point-of-care Infectious Disease Diagnostics Market Share by Players (2018-2023)
Table 23. Global Top Point-of-care Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2022)
Table 24. Ranking of Global Top Point-of-care Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2022
Table 25. Global 5 Largest Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service
Table 28. Date of Enter into Point-of-care Infectious Disease Diagnostics Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Point-of-care Infectious Disease Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 31. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2018-2023)
Table 32. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 33. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2024-2033)
Table 34. Global Point-of-care Infectious Disease Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 35. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Application (2018-2023)
Table 36. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 37. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Application (2024-2033)
Table 38. North America Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 44. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 45. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 46. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 47. Latin America Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 49. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 50. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 51. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 52. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 53. Thermo Fisher Scientific Company Detail
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Product
Table 56. Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 57. Thermo Fisher Scientific Recent Development
Table 58. Abbott Company Detail
Table 59. Abbott Business Overview
Table 60. Abbott Point-of-care Infectious Disease Diagnostics Product
Table 61. Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 62. Abbott Recent Development
Table 63. Calypte Biomedical Company Detail
Table 64. Calypte Biomedical Business Overview
Table 65. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Product
Table 66. Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 67. Calypte Biomedical Recent Development
Table 68. Chembio Diagnostic Systems Company Detail
Table 69. Chembio Diagnostic Systems Business Overview
Table 70. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Product
Table 71. Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 72. Chembio Diagnostic Systems Recent Development
Table 73. Meridian Bioscience Company Detail
Table 74. Meridian Bioscience Business Overview
Table 75. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Product
Table 76. Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 77. Meridian Bioscience Recent Development
Table 78. MedMira Company Detail
Table 79. MedMira Business Overview
Table 80. MedMira Point-of-care Infectious Disease Diagnostics Product
Table 81. MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 82. MedMira Recent Development
Table 83. Trinity Biotech Company Detail
Table 84. Trinity Biotech Business Overview
Table 85. Trinity Biotech Point-of-care Infectious Disease Diagnostics Product
Table 86. Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 87. Trinity Biotech Recent Development
Table 88. Sekisui Diagnostics Company Detail
Table 89. Sekisui Diagnostics Business Overview
Table 90. Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Product
Table 91. Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 92. Sekisui Diagnostics Recent Development
Table 93. OraSure Technologies Company Detail
Table 94. OraSure Technologies Business Overview
Table 95. OraSure Technologies Point-of-care Infectious Disease Diagnostics Product
Table 96. OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 97. OraSure Technologies Recent Development
Table 98. Quidel Company Detail
Table 99. Quidel Business Overview
Table 100. Quidel Point-of-care Infectious Disease Diagnostics Product
Table 101. Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 102. Quidel Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point-of-care Infectious Disease Diagnostics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Point-of-care Infectious Disease Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. HIV POC Features
Figure 4. Clostridium Difficile POC Features
Figure 5. HBV POC Features
Figure 6. Respiratory Syncytial Virus POC Features
Figure 7. HPV POC Features
Figure 8. Influenza/Flu POC Features
Figure 9. HCV POC Features
Figure 10. MRSA POC Features
Figure 11. TB and Drug-Resistant TB POC Features
Figure 12. Global Point-of-care Infectious Disease Diagnostics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 13. Global Point-of-care Infectious Disease Diagnostics Market Share by Application: 2022 VS 2033
Figure 14. Hospitals Case Studies
Figure 15. Clinics Case Studies
Figure 16. Home Case Studies
Figure 17. Assisted Living Healthcare Facilities Case Studies
Figure 18. Laboratories Case Studies
Figure 19. Others Case Studies
Figure 20. Point-of-care Infectious Disease Diagnostics Report Years Considered
Figure 21. Global Point-of-care Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 22. Global Point-of-care Infectious Disease Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 23. Global Point-of-care Infectious Disease Diagnostics Market Share by Region: 2022 VS 2033
Figure 24. Global Point-of-care Infectious Disease Diagnostics Market Share by Players in 2022
Figure 25. Global Top Point-of-care Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2022)
Figure 26. The Top 10 and 5 Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue in 2022
Figure 27. North America Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. North America Point-of-care Infectious Disease Diagnostics Market Share by Country (2018-2033)
Figure 29. United States Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Canada Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Europe Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Europe Point-of-care Infectious Disease Diagnostics Market Share by Country (2018-2033)
Figure 33. Germany Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. France Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. U.K. Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Italy Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Russia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Nordic Countries Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Share by Region (2018-2033)
Figure 41. China Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Japan Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Latin America Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Latin America Point-of-care Infectious Disease Diagnostics Market Share by Country (2018-2033)
Figure 49. Mexico Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Brazil Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Share by Country (2018-2033)
Figure 53. Turkey Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
Figure 56. Abbott Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
Figure 57. Calypte Biomedical Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
Figure 58. Chembio Diagnostic Systems Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
Figure 59. Meridian Bioscience Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
Figure 60. MedMira Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
Figure 61. Trinity Biotech Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
Figure 62. Sekisui Diagnostics Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
Figure 63. OraSure Technologies Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
Figure 64. Quidel Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed